Previously operating as a subsiduary of Shifamed LLC, Apama Medical was acquired by Boston Scientiifc in October 2017. The firm had been an early-stage company focused on the treatment of atrial fibrillation (AF) by developing novel catheter ablation technology. Recognizing the need for a more effective means of treating atrial fibrillation, Apama Medical is developing an ablation catheter technology combining the best elements of existing ablation technology, while incorporating additional unique features to address gaps in current technology. Approach significantly reduces procedure time due to multipoint, single-shot design and optimizes lesion placement via real-time visualization, provides solutions for patients with various AF types due to its ability to create customizable lesion patterns with the incorporated irrigation reducing risk of clot formation
